| Host |
Mouse |
| Clone |
SYP02 |
| Format |
Concentrate |
| Method |
F, P |
| Pretreatment |
Citrate |
| Positive control |
Pancreas |
| Dilution |
ready-to-use |
| Isotype |
Mouse IgG1 |
| Localization |
Cytoplasm |
Synaptophysin
|
Diagnostic Biosystems |
SYP02 |
6 ml |
Concentrate |
CE/IVD |
PDM592 |
-
|
| Host |
Monospecific Mouse |
| Clone |
ZM208 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Pancreas. |
| Dilution |
1:100 |
| Isotype |
IgG1 /κ |
| Immunogen |
Synthetic peptide within Human Synaptophysin aa 200-300 |
| Localization |
Cytoplasm |
Synaptophysin
|
Zeta Corporation |
ZM208 |
1 ml |
Concentrate |
CE/IVD |
Z2544ML |
-
|
| Host |
Monospecific Mouse |
| Clone |
ZM208 |
| Format |
Ready-to-use |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Pancreas. |
| Dilution |
- |
| Isotype |
IgG1 /κ |
| Immunogen |
Synthetic peptide within Human Synaptophysin aa 200-300 |
| Localization |
Cytoplasm |
Synaptophysin
|
Zeta Corporation |
ZM208 |
7 ml |
Ready-to-use |
CE/IVD |
Z2544MP |
-
|
| Host |
Monospecific Mouse |
| Clone |
ZM208 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Pancreas. |
| Dilution |
1:100 |
| Isotype |
IgG1 /κ |
| Immunogen |
Synthetic peptide within Human Synaptophysin aa 200-300 |
| Localization |
Cytoplasm |
Synaptophysin
|
Zeta Corporation |
ZM208 |
0.5 ml |
Concentrate |
CE/IVD |
Z2544MS |
-
|
| Host |
Monospecific Mouse |
| Clone |
ZM208 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Pancreas. |
| Dilution |
1:100 |
| Isotype |
IgG1 /κ |
| Immunogen |
Synthetic peptide within Human Synaptophysin aa 200-300 |
| Localization |
Cytoplasm |
Synaptophysin
|
Zeta Corporation |
ZM208 |
0.1 ml |
Concentrate |
CE/IVD |
Z2544MT |
-
|
| Host |
Rabbit |
| Clone |
SP70 |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
Citrate |
| Positive control |
Breast Carcinoma |
| Dilution |
1:100 |
| Isotype |
Rabbit IgG |
| Immunogen |
Synthetic peptide derived from N-terminus of human tau protein. |
| Localization |
Cytoplasm |
TAU
|
Zytomed Systems GmbH |
SP70 |
1 ml |
Concentrate |
RUO |
520-3704 |
-
|
| Host |
Mouse |
| Clone |
Tau46 |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
EDTA |
| Positive control |
Alzheimer Brain |
| Dilution |
1:25 - 1:50 |
| Isotype |
Mouse IgG1 |
| Localization |
Cytoplasm |
TAU
|
Diagnostic Biosystems |
Tau46 |
0.1 ml |
Concentrate |
CE/IVD |
MOB472-01 |
-
|
| Host |
Mouse |
| Clone |
Tau46 |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
EDTA |
| Positive control |
Alzheimer Brain |
| Dilution |
1:25 - 1:50 |
| Isotype |
Mouse IgG1 |
| Localization |
Cytoplasm |
TAU
|
Diagnostic Biosystems |
Tau46 |
0.5 ml |
Concentrate |
CE/IVD |
MOB472-05 |
-
|
| Host |
Mouse |
| Clone |
ZM92 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Tonsil. |
| Dilution |
1:50 - 1:100 |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant human TCL1 protein fragment (around aa 2-109) |
| Localization |
Cytoplasm |
TCL1
|
Zeta Corporation |
ZM92 |
1 ml |
Concentrate |
CE/IVD |
Z2402ML |
-
|
| Host |
Mouse |
| Clone |
ZM92 |
| Format |
Ready-to-use |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Tonsil. |
| Dilution |
- |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant human TCL1 protein fragment (around aa 2-109) |
| Localization |
Cytoplasm |
TCL1
|
Zeta Corporation |
ZM92 |
7 ml |
Ready-to-use |
CE/IVD |
Z2402MP |
-
|
| Host |
Mouse |
| Clone |
ZM92 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Tonsil. |
| Dilution |
1:50 - 1:100 |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant human TCL1 protein fragment (around aa 2-109) |
| Localization |
Cytoplasm |
TCL1
|
Zeta Corporation |
ZM92 |
0.5 ml |
Concentrate |
CE/IVD |
Z2402MS |
-
|
| Host |
Mouse |
| Clone |
ZM92 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Tonsil. |
| Dilution |
1:50 - 1:100 |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant human TCL1 protein fragment (around aa 2-109) |
| Localization |
Cytoplasm |
TCL1
|
Zeta Corporation |
ZM92 |
0.1 ml |
Concentrate |
CE/IVD |
Z2402MT |
-
|
| Host |
Mouse |
| Clone |
3A8 |
| Format |
Purified |
| Method |
F, IP |
| Isotype |
Mouse IgG2a |
TCR, alpha (T-Cell Receptor)
|
Zytomed Systems GmbH |
3A8 |
100 µg |
Purified |
RUO |
620-0019 |
-
|
| Host |
Mouse |
| Clone |
3A8 |
| Format |
Purified |
| Method |
F, IP |
| Isotype |
Mouse IgG2a |
TCR, alpha (T-Cell Receptor)
|
Zytomed Systems GmbH |
3A8 |
50 µg |
Purified |
RUO |
620-0020 |
-
|
| Host |
Hamster |
| Clone |
H57-597 |
| Format |
Purified |
| Method |
IP, FL |
| Isotype |
Hamster IgG |
| Immunogen |
Affinity purified murine T cell receptor |
TCR, alpha, beta (T-Cell Receptor)
|
Zytomed Systems GmbH |
H57-597 |
250 µg |
Purified |
RUO |
620-0021 |
-
|
| Host |
Mouse |
| Clone |
R73 |
| Format |
Purified |
| Method |
F, IP, FL |
| Isotype |
Mouse IgG1 |
| Immunogen |
Rat T blasts and erythrocytes |
TCR, alpha, beta (T-Cell Receptor)
|
Zytomed Systems GmbH |
R73 |
100 µg |
Purified |
RUO |
620-0024 |
-
|
| Host |
Mouse |
| Clone |
V65 |
| Format |
Purified |
| Method |
F, IP, FL |
| Isotype |
Mouse IgG1 |
| Immunogen |
CD3 +ve TCR alpha/beta -ve rat T cell hybridoma line |
TCR, gamma, delta (T-Cell Receptor)
|
Zytomed Systems GmbH |
V65 |
250 µg |
Purified |
RUO |
620-0037 |
-
|
| Host |
Mouse |
| Clone |
SEN28 |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
EDTA |
| Positive control |
Thymus |
| Dilution |
1:10 - 1:50 |
| Isotype |
Mouse IgG2a |
| Immunogen |
Recombinant protein corresponding to the amino terminal region of TdT molecule |
| Localization |
Nucleus |
TdT (Terminal Desoxynucleotidyl Transferase)
|
Diagnostic Biosystems |
SEN28 |
1 ml |
Concentrate |
CE/IVD |
MOB545 |
-
|
| Host |
Mouse |
| Clone |
SEN28 |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
EDTA |
| Positive control |
Thymus |
| Dilution |
1:10 - 1:50 |
| Isotype |
Mouse IgG2a |
| Immunogen |
Recombinant protein corresponding to the amino terminal region of TdT molecule |
| Localization |
Nucleus |
TdT (Terminal Desoxynucleotidyl Transferase)
|
Diagnostic Biosystems |
SEN28 |
0.1 ml |
Concentrate |
CE/IVD |
MOB545-01 |
-
|
| Host |
Mouse |
| Clone |
SEN28 |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
EDTA |
| Positive control |
Thymus |
| Dilution |
1:10 - 1:50 |
| Isotype |
Mouse IgG2a |
| Immunogen |
Recombinant protein corresponding to the amino terminal region of TdT molecule |
| Localization |
Nucleus |
TdT (Terminal Desoxynucleotidyl Transferase)
|
Diagnostic Biosystems |
SEN28 |
0.5 ml |
Concentrate |
CE/IVD |
MOB545-05 |
-
|
| Host |
Mouse |
| Clone |
SEN28 |
| Format |
Ready-to-use |
| Method |
P |
| Pretreatment |
EDTA |
| Positive control |
Thymus |
| Dilution |
- |
| Isotype |
Mouse IgG2a |
| Immunogen |
Recombinant protein corresponding to the amino terminal region of TdT molecule |
| Localization |
Nucleus |
TdT (Terminal Desoxynucleotidyl Transferase)
|
Diagnostic Biosystems |
SEN28 |
6 ml |
Ready-to-use |
CE/IVD |
PDM096 |
-
|
| Host |
Monospecific Mouse |
| Clone |
ZM51 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Thymus. |
| Dilution |
1:50 - 1:100 |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant fragment (around aa 52-192) of human DNTT protein |
| Localization |
Nucleus |
TdT (Terminal Desoxynucleotidyl Transferase)
|
Zeta Corporation |
ZM51 |
1 ml |
Concentrate |
CE/IVD |
Z2391ML |
-
|
| Host |
Monospecific Mouse |
| Clone |
ZM51 |
| Format |
Ready-to-use |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Thymus. |
| Dilution |
- |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant fragment (around aa 52-192) of human DNTT protein |
| Localization |
Nucleus |
TdT (Terminal Desoxynucleotidyl Transferase)
|
Zeta Corporation |
ZM51 |
7 ml |
Ready-to-use |
CE/IVD |
Z2391MP |
-
|
| Host |
Monospecific Mouse |
| Clone |
ZM51 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Thymus. |
| Dilution |
1:50 - 1:100 |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant fragment (around aa 52-192) of human DNTT protein |
| Localization |
Nucleus |
TdT (Terminal Desoxynucleotidyl Transferase)
|
Zeta Corporation |
ZM51 |
0.5 ml |
Concentrate |
CE/IVD |
Z2391MS |
-
|
| Host |
Monospecific Mouse |
| Clone |
ZM51 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Thymus. |
| Dilution |
1:50 - 1:100 |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant fragment (around aa 52-192) of human DNTT protein |
| Localization |
Nucleus |
TdT (Terminal Desoxynucleotidyl Transferase)
|
Zeta Corporation |
ZM51 |
0.1 ml |
Concentrate |
CE/IVD |
Z2391MT |
-
|
| Host |
Mouse |
| Clone |
T2H5 |
| Format |
Purified |
| Method |
P, F, WB, IP, EL |
| Pretreatment |
Citrate oder Trypsin |
| Positive control |
Human tonsil |
| Isotype |
Mouse IgG1 |
| Immunogen |
Native purified protein from human mammary tumour |
Tenascin
|
Zytomed Systems GmbH |
T2H5 |
200 µg (200 µl) |
Purified |
RUO |
620-0072 |
-
|
| Host |
Mouse |
| Clone |
DB7 |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
EDTA |
| Positive control |
Tonsil, appendix |
| Dilution |
1:50 - 1:200 |
| Isotype |
IgG2a |
| Localization |
Extracellular |
Tenascin C (TNC)
|
Zytomed Systems GmbH |
DB7 |
0.5 ml |
Concentrate |
RUO |
MSK104-05 |
-
|
| Host |
Rabbit |
| Clone |
ZR365 |
| Format |
concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Testis |
| Dilution |
1:100-1:200 |
| Isotype |
IgG |
| Immunogen |
Recombinant full-length human TFE3 protein |
| Localization |
Nucleus |
TFE3
|
Zeta Corporation |
ZR365 |
1 ml |
concentrate |
CE/IVD |
Z2605RL |
-
|
| Host |
Rabbit |
| Clone |
ZR365 |
| Format |
Ready-to-use |
| Reactivity |
- |
| Method |
P |
| Positive control |
Testis |
| Dilution |
- |
| Isotype |
IgG |
| Immunogen |
Recombinant full-length human TFE3 protein |
| Localization |
Nucleus |
TFE3
|
Zeta Corporation |
ZR365 |
7 ml |
Ready-to-use |
CE/IVD |
Z2605RP |
-
|
| Host |
Rabbit |
| Clone |
ZR365 |
| Format |
concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Testis |
| Dilution |
1:100-1:200 |
| Isotype |
IgG |
| Immunogen |
Recombinant full-length human TFE3 protein |
| Localization |
Nucleus |
TFE3
|
Zeta Corporation |
ZR365 |
0.5 ml |
concentrate |
CE/IVD |
Z2605RS |
-
|
| Host |
Rabbit |
| Clone |
ZR365 |
| Format |
concentrate |
| Reactivity |
- |
| Method |
P |
| Positive control |
Testis |
| Dilution |
1:100-1:200 |
| Isotype |
IgG |
| Immunogen |
Recombinant full-length human TFE3 protein |
| Localization |
Nucleus |
TFE3
|
Zeta Corporation |
ZR365 |
0.1 ml |
concentrate |
CE/IVD |
Z2605RT |
-
|
| Host |
Monospecific Mouse |
| Clone |
ZM105 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Mesothelioma. |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG2a /κ |
| Immunogen |
Recombinant human thrombomodulin protein fragment (aa69-194) |
| Localization |
Cytoplasm |
Thrombomodulin
|
Zeta Corporation |
ZM105 |
1 ml |
Concentrate |
CE/IVD |
Z2416ML |
-
|
| Host |
Monospecific Mouse |
| Clone |
ZM105 |
| Format |
Ready-to-use |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Mesothelioma. |
| Dilution |
- |
| Isotype |
IgG2a /κ |
| Immunogen |
Recombinant human thrombomodulin protein fragment (aa69-194) |
| Localization |
Cytoplasm |
Thrombomodulin
|
Zeta Corporation |
ZM105 |
7 ml |
Ready-to-use |
CE/IVD |
Z2416MP |
-
|
| Host |
Monospecific Mouse |
| Clone |
ZM105 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Mesothelioma. |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG2a /κ |
| Immunogen |
Recombinant human thrombomodulin protein fragment (aa69-194) |
| Localization |
Cytoplasm |
Thrombomodulin
|
Zeta Corporation |
ZM105 |
0.5 ml |
Concentrate |
CE/IVD |
Z2416MS |
-
|
| Host |
Monospecific Mouse |
| Clone |
ZM105 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
Mesothelioma. |
| Dilution |
1:100 - 1:200 |
| Isotype |
IgG2a /κ |
| Immunogen |
Recombinant human thrombomodulin protein fragment (aa69-194) |
| Localization |
Cytoplasm |
Thrombomodulin
|
Zeta Corporation |
ZM105 |
0.1 ml |
Concentrate |
CE/IVD |
Z2416MT |
-
|
| Host |
Mouse |
| Clone |
A6.1 |
| Format |
Concentrate |
| Method |
F, P, IF, IP, WB |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
1:25 - 1:50 |
| Isotype |
Mouse IgG1 |
| Localization |
Secretory Granules, Golgi Complex, Endoplasmic Reticulum |
Thrombospondin (TSP)
|
Diagnostic Biosystems |
A6.1 |
1 ml |
Concentrate |
CE/IVD |
MOB315 |
-
|
| Host |
Mouse |
| Clone |
A6.1 |
| Format |
Concentrate |
| Method |
F, P, IF, IP, WB |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
1:25 - 1:50 |
| Isotype |
Mouse IgG1 |
| Localization |
Secretory Granules, Golgi Complex, Endoplasmic Reticulum |
Thrombospondin (TSP)
|
Diagnostic Biosystems |
A6.1 |
0.1 ml |
Concentrate |
CE/IVD |
MOB315-01 |
-
|
| Host |
Mouse |
| Clone |
A6.1 |
| Format |
Concentrate |
| Method |
F, P, IF, IP, WB |
| Pretreatment |
Citrate |
| Positive control |
Tonsil |
| Dilution |
1:25 - 1:50 |
| Isotype |
Mouse IgG1 |
| Localization |
Secretory Granules, Golgi Complex, Endoplasmic Reticulum |
Thrombospondin (TSP)
|
Diagnostic Biosystems |
A6.1 |
0.5 ml |
Concentrate |
CE/IVD |
MOB315-05 |
-
|
| Host |
Mouse |
| Clone |
P-GF.44C |
| Format |
Concentrate |
| Method |
F, P, WB |
| Positive control |
Breast Carcinoma |
| Dilution |
1:25 - 1:75 |
| Isotype |
Mouse IgG1 |
| Localization |
Cytoplasm, nucleus |
Thymidine Phosphorylase
|
Diagnostic Biosystems |
P-GF.44C |
1 ml |
Concentrate |
CE/IVD |
MOB292 |
-
|
| Host |
Mouse |
| Clone |
P-GF.44C |
| Format |
Concentrate |
| Method |
F, P, WB |
| Positive control |
Breast Carcinoma |
| Dilution |
1:25 - 1:75 |
| Isotype |
Mouse IgG1 |
| Localization |
Cytoplasm, nucleus |
Thymidine Phosphorylase
|
Diagnostic Biosystems |
P-GF.44C |
0.1 ml |
Concentrate |
CE/IVD |
MOB292-01 |
-
|
| Host |
Mouse |
| Clone |
P-GF.44C |
| Format |
Concentrate |
| Method |
F, P, WB |
| Positive control |
Breast Carcinoma |
| Dilution |
1:25 - 1:75 |
| Isotype |
Mouse IgG1 |
| Localization |
Cytoplasm, nucleus |
Thymidine Phosphorylase
|
Diagnostic Biosystems |
P-GF.44C |
0.5 ml |
Concentrate |
CE/IVD |
MOB292-05 |
-
|
| Host |
Rabbit |
| Clone |
SP112 |
| Format |
Concentrate |
| Method |
P |
| Pretreatment |
EDTA |
| Positive control |
Colon Carcinoma, tonsil |
| Dilution |
1:100 |
| Isotype |
Rabbit IgG |
| Immunogen |
Synthetic peptide near C-terminus of human TS |
| Localization |
Cytoplasm, nucleus |
Thymidylate Synthase (TS)
|
Zytomed Systems GmbH |
SP112 |
1 ml |
Concentrate |
RUO |
520-4124 |
-
|
| Host |
Mouse |
| Clone |
TS106 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
5-FU resistant cancer. |
| Dilution |
1:50 |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant human thymidylate synthase |
| Localization |
Cytoplasm |
Thymidylate Synthase (TS)
|
Zeta Corporation |
TS106 |
1 ml |
Concentrate |
CE/IVD |
Z2199ML |
-
|
| Host |
Mouse |
| Clone |
TS106 |
| Format |
Ready-to-use |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
5-FU resistant cancer. |
| Dilution |
- |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant human thymidylate synthase |
| Localization |
Cytoplasm |
Thymidylate Synthase (TS)
|
Zeta Corporation |
TS106 |
7 ml |
Ready-to-use |
CE/IVD |
Z2199MP |
-
|
| Host |
Mouse |
| Clone |
TS106 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
5-FU resistant cancer. |
| Dilution |
1:50 |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant human thymidylate synthase |
| Localization |
Cytoplasm |
Thymidylate Synthase (TS)
|
Zeta Corporation |
TS106 |
0.5 ml |
Concentrate |
CE/IVD |
Z2199MS |
-
|
| Host |
Mouse |
| Clone |
TS106 |
| Format |
Concentrate |
| Reactivity |
- |
| Method |
P |
| Pretreatment |
Citrate or EDTA |
| Positive control |
5-FU resistant cancer. |
| Dilution |
1:50 |
| Isotype |
IgG1 /κ |
| Immunogen |
Recombinant human thymidylate synthase |
| Localization |
Cytoplasm |
Thymidylate Synthase (TS)
|
Zeta Corporation |
TS106 |
0.1 ml |
Concentrate |
CE/IVD |
Z2199MT |
-
|
| Host |
Mouse |
| Clone |
1D4 |
| Format |
Concentrate |
| Method |
F, P |
| Positive control |
Thyroid |
| Dilution |
1:25 - 1:50 |
| Isotype |
Mouse IgG2a |
| Localization |
Cytoplasm |
Thyroglobulin
|
Diagnostic Biosystems |
1D4 |
1 ml |
Concentrate |
CE/IVD |
MOB223 |
-
|
| Host |
Mouse |
| Clone |
1D4 |
| Format |
Concentrate |
| Method |
F, P |
| Positive control |
Thyroid |
| Dilution |
1:25 - 1:50 |
| Isotype |
Mouse IgG2a |
| Localization |
Cytoplasm |
Thyroglobulin
|
Diagnostic Biosystems |
1D4 |
0.1 ml |
Concentrate |
CE/IVD |
MOB223-01 |
-
|
| Host |
Mouse |
| Clone |
1D4 |
| Format |
Concentrate |
| Method |
F, P |
| Positive control |
Thyroid |
| Dilution |
1:25 - 1:50 |
| Isotype |
Mouse IgG2a |
| Localization |
Cytoplasm |
Thyroglobulin
|
Diagnostic Biosystems |
1D4 |
0.5 ml |
Concentrate |
CE/IVD |
MOB223-05 |
-
|
| Host |
Mouse |
| Clone |
1D4 |
| Format |
Ready-to-use |
| Method |
P |
| Positive control |
Thyroid |
| Dilution |
- |
| Isotype |
Mouse IgG2a |
| Localization |
Cytoplasm |
Thyroglobulin
|
Diagnostic Biosystems |
1D4 |
6 ml |
Ready-to-use |
CE/IVD |
PDM576 |
-
|